BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16220074)

  • 1. Differentiation of L- and D-S-nitrosothiol recognition sites in vivo.
    Lewis SJ; Hoque A; Bates JN
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):660-71. PubMed ID: 16220074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxynitrite elicits dysfunction of stereoselective s-nitrosocysteine recognition sites.
    Lewis SJ; Graves JE; Bates JN; Kooy NW
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):637-45. PubMed ID: 16220071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.
    Lewis SJ; Travis MD; Hashmi-Hill MP; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Dec; 45(6):383-94. PubMed ID: 16861050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox regulation of S-nitrosocysteine-mediated vasodilation in vivo.
    Hoque A; Bates JN; Lewis SJ
    Eur J Pharmacol; 2000 Nov; 408(2):195-8. PubMed ID: 11080526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of L- and D-S-nitroso-beta,beta-dimethylcysteine in rats.
    Travis MD; Davisson RL; Bates JN; Lewis SJ
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1493-501. PubMed ID: 9321842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of L- and D-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites.
    Davisson RL; Travis MD; Bates JN; Lewis SJ
    Circ Res; 1996 Aug; 79(2):256-62. PubMed ID: 8756002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo.
    Travis MD; Hoque A; Bates JN; Lewis SJ
    Eur J Pharmacol; 2000 Nov; 408(3):289-98. PubMed ID: 11090646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective actions of S-nitrosocysteine in central nervous system of conscious rats.
    Davisson RL; Travis MD; Bates JN; Johnson AK; Lewis SJ
    Am J Physiol; 1997 May; 272(5 Pt 2):H2361-8. PubMed ID: 9176306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator actions of the endothelium-derived relaxing factor L-S-nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite.
    Graves JE; Bates JN; Kooy NW; Lewis SJ
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1137-41. PubMed ID: 16445582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ATP-sensitive K+ -channels in hemodynamic effects of peroxynitrite in anesthetized rats.
    Graves JE; Lewis SJ; Kooy NW
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):653-9. PubMed ID: 16220073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of nitroblue tetrazolium on the hemodynamic responses elicited by activation of alpha1-adrenoceptors and 5-HT2 receptors in conscious rats.
    Owen JR; Bates JN; Lewis SJ
    Eur J Pharmacol; 2006 Mar; 535(1-3):248-52. PubMed ID: 16527267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence that L-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature.
    Hoque A; Bates JN; Lewis SJ
    Eur J Pharmacol; 1999 Nov; 384(2-3):169-72. PubMed ID: 10611438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of beta-adrenoceptor sub-types in the rat.
    Lewis SJ; Hoque A; Walton TM; Kooy NW
    Eur J Pharmacol; 2005 Aug; 518(2-3):187-94. PubMed ID: 16043170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent association of MK-801-sensitive ion channels with L-S-nitrosocysteine recognition sites in the hindlimb vasculature of the rat.
    Travis MD; Lewis SJ
    Eur J Pharmacol; 2000 Nov; 407(3):309-12. PubMed ID: 11068027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenoceptor dysfunction after inhibition of NO synthesis.
    Whalen EJ; Johnson AK; Lewis SJ
    Hypertension; 2000 Sep; 36(3):376-82. PubMed ID: 10988268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-nitrosocysteine elicits hemodynamic responses similar to those of the Bezold-Jarisch reflex via activation of stereoselective recognition sites.
    Lewis SJ; Owen JR; Bates JN
    Eur J Pharmacol; 2006 Feb; 531(1-3):254-8. PubMed ID: 16438953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide inhibits acetylcholine- and nitric oxide-mediated vasodilation in vivo.
    Peters TS; Lewis SJ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):918-25. PubMed ID: 8930200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The myth of nitric oxide in central cardiovascular control by the nucleus tractus solitarii.
    Talman WT
    Braz J Med Biol Res; 1997 Apr; 30(4):515-20. PubMed ID: 9251773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.